Endogenous Glucagon-like Peptide-1 Suppresses High-Fat Food Intake by Reducing Synaptic Drive onto Mesolimbic Dopamine Neurons

Cell Reports

Volumn 12, Issue 5, 2015, Pages 726-733

  Wang, Xue Feng ^a   Liu, Jing Jing ^a   Xia, Julia ^a   Liu, Ji ^a   Mirabella, Vincent ^a   Pang, Zhiping P ^a,b  

^a CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; FAT INTAKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CELL; BRAIN STEM; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FAT INTAKE; FEEDING BEHAVIOR; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NEUROPHYSIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PALATABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM; ANIMAL; CYTOLOGY; EATING; METABOLISM; PHYSIOLOGY; SYNAPSE; TRANSGENIC MOUSE;

ANIMALS; DIETARY FATS; DOPAMINERGIC NEURONS; EATING; GLUCAGON-LIKE PEPTIDE 1; MICE; MICE, TRANSGENIC; NUCLEUS ACCUMBENS; SIGNAL TRANSDUCTION; SYNAPSES; VENTRAL TEGMENTAL AREA;

EID: 84938553210     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.06.062     Document Type: Article

References (38)

1. Acuna-Goycolea C., van den Pol A. Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal. J. Neurosci. 2004, 24:8141-8152.
2. Alhadeff A.L., Grill H.J. Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2014, 307:R465-R470.
3. Alhadeff A.L., Rupprecht L.E., Hayes M.R. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 2012, 153:647-658.
4. Chieng B., Azriel Y., Mohammadi S., Christie M.J. Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J. Physiol. 2011, 589:3775-3787.
5. Dickson S.L., Shirazi R.H., Hansson C., Bergquist F., Nissbrandt H., Skibicka K.P. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J. Neurosci. 2012, 32:4812-4820.
6. Dossat A.M., Lilly N., Kay K., Williams D.L. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J. Neurosci. 2011, 31:14453-14457.
7. Dossat A.M., Diaz R., Gallo L., Panagos A., Kay K., Williams D.L. Nucleus accumbens GLP-1 receptors influence meal size and palatability. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E1314-E1320.
8. Drucker D.J., Buse J.B., Taylor K., Kendall D.M., Trautmann M., Zhuang D., Porter L. Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet 2008, 372:1240-1250. DURATION-1 Study Group.
9. Egecioglu E., Steensland P., Fredriksson I., Feltmann K., Engel J.A., Jerlhag E. The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents. Psychoneuroendocrinology 2013, 38:1259-1270.
10. Gu G., Roland B., Tomaselli K., Dolman C.S., Lowe C., Heilig J.S. Glucagon-like peptide-1 in the rat brain: distribution of expression and functional implication. J. Comp. Neurol. 2013, 521:2235-2261.
11. Hsu T.M., Hahn J.D., Konanur V.R., Lam A., Kanoski S.E. Hippocampal GLP-1 receptors influence food intake, meal size, and effort-based responding for food through volume transmission. Neuropsychopharmacology 2015, 40:327-337.
12. Johnson S.W., North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. 1992, 450:455-468.
13. Kenny P.J. Reward mechanisms in obesity: new insights and future directions. Neuron 2011, 69:664-679.
14. Lammel S., Ion D.I., Roeper J., Malenka R.C. Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 2011, 70:855-862.
15. Lammel S., Lim B.K., Ran C., Huang K.W., Betley M.J., Tye K.M., Deisseroth K., Malenka R.C. Input-specific control of reward and aversion in the ventral tegmental area. Nature 2012, 491:212-217.
16. Liu J.J., Mukherjee D., Haritan D., Ignatowska-Jankowska B., Liu J., Citri A., Pang Z.P. High on food: the interaction between the neural circutis for feeding and for reward. Front. Biol. 2015, Published online July 11, 2015. 10.1007/s11515-015-1348-0.
17. Lovshin J.A., Drucker D.J. Incretin-based therapies for type 2 diabetes mellitus. Nat. Rev. Endocrinol. 2009, 5:262-269.
18. Medic N., Ziauddeen H., Vestergaard M.D., Henning E., Schultz W., Farooqi I.S., Fletcher P.C. Dopamine modulates the neural representation of subjective value of food in hungry subjects. J. Neurosci. 2014, 34:16856-16864.
19. Meeran K., O'Shea D., Edwards C.M., Turton M.D., Heath M.M., Gunn I., Abusnana S., Rossi M., Small C.J., Goldstone A.P., et al. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology 1999, 140:244-250.
20. Merchenthaler I., Lane M., Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J. Comp. Neurol. 1999, 403:261-280.
21. Mietlicki-Baase E.G., Ortinski P.I., Rupprecht L.E., Olivos D.R., Alhadeff A.L., Pierce R.C., Hayes M.R. The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors. Am. J. Physiol. Endocrinol. Metab. 2013, 305:E1367-E1374.
22. Mietlicki-Baase E.G., Ortinski P.I., Reiner D.J., Sinon C.G., McCutcheon J.E., Pierce R.C., Roitman M.F., Hayes M.R. Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling. J. Neurosci. 2014, 34:6985-6992.
23. Nakamura T., Barbara J.G., Nakamura K., Ross W.N. Synergistic release of Ca2+ from IP3-sensitive stores evoked by synaptic activation of mGluRs paired with backpropagating action potentials. Neuron 1999, 24:727-737.
24. Pang Z.P., Deng P., Ruan Y.W., Xu Z.C. Depression of fast excitatory synaptic transmission in large aspiny neurons of the neostriatum after transient forebrain ischemia. J. Neurosci. 2002, 22:10948-10957.
25. Pei Y., Rogan S.C., Yan F., Roth B.L. Engineered GPCRs as tools to modulate signal transduction. Physiology (Bethesda) 2008, 23:313-321.
26. Rhee J.S., Betz A., Pyott S., Reim K., Varoqueaux F., Augustin I., Hesse D., Südhof T.C., Takahashi M., Rosenmund C., Brose N. Beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs. Cell 2002, 108:121-133.
27. Scott M.M., Williams K.W., Rossi J., Lee C.E., Elmquist J.K. Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in mice. J. Clin. Invest. 2011, 121:2413-2421.
28. Secher A., Jelsing J., Baquero A.F., Hecksher-Sørensen J., Cowley M.A., Dalbøge L.S., Hansen G., Grove K.L., Pyke C., Raun K., et al. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J. Clin. Invest. 2014, 124:4473-4488.
29. Shirazi R.H., Dickson S.L., Skibicka K.P. Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward. PLoS ONE 2013, 8:e61965.
30. Sisley S., Gutierrez-Aguilar R., Scott M., D'Alessio D.A., Sandoval D.A., Seeley R.J. Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect. J. Clin. Invest. 2014, 124:2456-2463.
31. Sternson S.M., Roth B.L. Chemogenetic tools to interrogate brain functions. Annu. Rev. Neurosci. 2014, 37:387-407.
32. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M., Meeran K., Choi S.J., Taylor G.M., Heath M.M., Lambert P.D., et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996, 379:69-72.
33. Ungless M.A., Grace A.A. Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci. 2012, 35:422-430.
34. U.S. Food and Drug Administration (2014). SAXENDA NDA 206321. REMS approval letter. December 2014. http://www.accessdata.fda.gov/drugsatfda_docs/rems/Saxenda_2014-12-23_REMS%20DOCUMENT%20.pdf.
35. Van Heek M., Compton D.S., France C.F., Tedesco R.P., Fawzi A.B., Graziano M.P., Sybertz E.J., Strader C.D., Davis H.R. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J. Clin. Invest. 1997, 99:385-390.
36. Volkow N.D., Wang G.J., Baler R.D. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn. Sci. 2011, 15:37-46.
37. Wan S., Coleman F.H., Travagli R.A. Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G1474-G1482.
38. Zheng H., Stornetta R.L., Agassandian K., Rinaman L. Glutamatergic phenotype of glucagon-like peptide 1 neurons in the caudal nucleus of the solitary tract in rats. Brain Struct. Funct. 2014, Published online July 11, 2014. 10.1007/s00429-014-0841-6.